The Division of Transplantation has earned acclaim from the international medical community for such breakthroughs as the UW-Belzer solution for organ preservation, research and clinical trials into the immunosuppressive drug mycophenolate mofetil, and improved surgical techniques for pancreas transplantation.
Current laboratory research includes programs in organ preservation, the development of new immunosuppressants, gene therapy for diabetes as an alternative to pancreas transplantation, and induction of immunological tolerance to organ transplantation as an alternative to lifelong immunosuppression.
The Division of Transplantation directs the NIH-funded T32 Transplant Research Training Program for MDs and PhDs who are strongly motivated toward a career in transplant-related research.
Active Clinical Trials
The Transplant Clinical Trials Office can be contacted at 608-263-2565.
Active Clinical Research >>
Latest Research News
Dr. David Schneider awarded grant for text analysis research
David Schneider, MD, MS, received a $50,000 grant from ICTR for “Computational Text Analysis for Measuring Quality of Life in Cancer Care.” Dr. Schneider will be developing automated text analysis tools that will enable clinicians …
The Arc of Discovery: How the transplant program uses collaborative research to improve outcomes for patients
The term “from bench to bedside” describes a common vision of medical research programs. The goal is to take research insights from laboratory settings to practical applications in patients as quickly as is practical, and …
Shapiro student honored for surgical research
This story was originally published at www.smph.wisc.edu. A third-year medical student at UW-Madison who is a research assistant with Department faculty recently received a prestigious national award for her work in surgical-education research. Kirsten Gunderson, …